← Leaderboards

Oguzhan Alagoz

University Of Wisconsin-Madison

Google Scholar ↗PubMed ↗ORCID ↗

$3,028,125

Attributed

$13,709,278

Total exposure

4

Grants

2

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY2007–25

$5M$3.8M$2.5M$1.3M$0

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$13,709,278 · 4

By mechanism

U01$10,631,912 · 1

R01$2,599,273 · 1

R21$338,613 · 1

R03$139,480 · 1

Top collaborators

Most similar at University Of Wisconsin-Madison

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsCessation Of LifeDiagnosisModels And SimulationBreastBiopsyIncidenceInnovationMortalityQuality Of LifeResourcesVirtual LaboratoryAccountingQuality-Adjusted Life YearsGuidelinesHealth PolicyClinically RelevantNatural HistoryWomanProgramsFutureCancer Intervention And Surveillance Modeling NetworkCancer ControlBenign

Grant awards (20)

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum Administrative Supplement$566,636

U01 · FY2025 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,508,560

U01 · FY2024 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$409,405

R01 · FY2024 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,871

U01 · FY2023 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$422,335

R01 · FY2023 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,791,664

U01 · FY2022 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760

U01 · FY2022 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$447,964

R01 · FY2022 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$120,485

R01 · FY2022 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum - Supplement$34,980

U01 · FY2022 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,967,606

U01 · FY2021 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$517,978

R01 · FY2021 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$503,760

U01 · FY2021 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$100,507

R01 · FY2021 · CA

Comparative Modeling of Precision Breast Cancer Control Across the Translational Continuum$1,963,075

U01 · FY2020 · CA

Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach$580,599

R01 · FY2020 · CA

Using Markov Decision Processes to Optimize Breast Biopsy Decision Making$153,320

R21 · FY2009 · CA · contact PI

Using Markov Decision Processes to Optimize Breast Biopsy Decision Making$185,293

R21 · FY2008 · CA · contact PI

Using the UWBCS to Assess Racial Disparities in Breast Cancer Incidence & Surviva$69,740

R03 · FY2008 · CA · contact PI

Using the UWBCS to Assess Racial Disparities in Breast Cancer Incidence & Surviva$69,740

R03 · FY2007 · CA · contact PI